The mechanisms responsible for the increased IL-8 expression induced by paclitaxel in ovarian cancer cells involve increased expression of toll-like receptors (TLRs) and increased p65 NFκB binding to IL-8 promoter [80,83]. This evidence concerns the gene NFKB1 and ovarian cancer.